ATE383357T1 - Acylderivate von 5-(2-(4-(1,2 benzisothiazol-3- yl)-1-piperazinyl)ethyl)-6-chloro-1,3-dihydro-2 - indol-2-on mit neuroleptischer wirkung - Google Patents

Acylderivate von 5-(2-(4-(1,2 benzisothiazol-3- yl)-1-piperazinyl)ethyl)-6-chloro-1,3-dihydro-2 - indol-2-on mit neuroleptischer wirkung

Info

Publication number: ATE383357T1
Authority: AT; Austria
Prior art keywords: benzisothiazole; indol; piperazinyl; dihydro; chloro
Prior art date: 2002-10-24

Application number

AT03751112T

Other languages

English (en)

Inventor

Timothy Norris

Roberto Colon-Cruz

Original Assignee

Pfizer Prod Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2002-10-24

Filing date

2003-10-13

Publication date

2008-01-15

2003-10-13 Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc

2008-01-15 Application granted granted Critical

2008-01-15 Publication of ATE383357T1 publication Critical patent/ATE383357T1/de

Links

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia

Landscapes

Organic Chemistry (AREA)
Chemical & Material Sciences (AREA)
Health & Medical Sciences (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Neurosurgery (AREA)
Life Sciences & Earth Sciences (AREA)
Biomedical Technology (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Veterinary Medicine (AREA)
Pharmacology & Pharmacy (AREA)
Neurology (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Psychiatry (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Plural Heterocyclic Compounds (AREA)
Indole Compounds (AREA)
Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

AT03751112T 2002-10-24 2003-10-13 Acylderivate von 5-(2-(4-(1,2 benzisothiazol-3- yl)-1-piperazinyl)ethyl)-6-chloro-1,3-dihydro-2 - indol-2-on mit neuroleptischer wirkung ATE383357T1 (de)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
US42084302P	2002-10-24	2002-10-24

Publications (1)

Publication Number	Publication Date
ATE383357T1 true ATE383357T1 (de)	2008-01-15

Family

ID=32176638

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT03751112T ATE383357T1 (de)	2002-10-24	2003-10-13	Acylderivate von 5-(2-(4-(1,2 benzisothiazol-3- yl)-1-piperazinyl)ethyl)-6-chloro-1,3-dihydro-2 - indol-2-on mit neuroleptischer wirkung

Country Status (24)

Country	Link
US (1)	US7019009B2 (de)
EP (1)	EP1556378B1 (de)
JP (1)	JP2006505578A (de)
KR (1)	KR100755625B1 (de)
CN (1)	CN100340557C (de)
AR (1)	AR041695A1 (de)
AT (1)	ATE383357T1 (de)
AU (1)	AU2003269331B2 (de)
BR (1)	BR0315516A (de)
CA (1)	CA2500485C (de)
CO (1)	CO5550441A2 (de)
CY (1)	CY1107300T1 (de)
DE (1)	DE60318602T2 (de)
DK (1)	DK1556378T3 (de)
ES (1)	ES2297200T3 (de)
MX (1)	MXPA05002734A (de)
NO (1)	NO20052475L (de)
NZ (1)	NZ566615A (de)
PL (1)	PL376721A1 (de)
PT (1)	PT1556378E (de)
RU (1)	RU2005112254A (de)
TW (1)	TW200418850A (de)
WO (1)	WO2004037819A1 (de)
ZA (1)	ZA200502109B (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CA2551346A1 (en) *	2003-12-31	2005-07-21	Warner-Lambert Company Llc	N-substituted piperidine and piperazine derivatives
US8431576B2 (en)	2009-06-25	2013-04-30	Alkermes Pharma Ireland Limited	Heterocyclic compounds for the treatment of neurological and psychological disorders
CA2937222C (en) *	2009-06-25	2019-06-04	Alkermes Pharma Ireland Limited	Prodrugs of nh-acidic compounds
ES2691671T3 (es) *	2010-06-24	2018-11-28	Alkermes Pharma Ireland Limited	Profármacos de compuestos NH-acídicos: derivados de éster, carbonato, carbamato y fosfonato
US20140206667A1 (en)	2012-11-14	2014-07-24	Michela Gallagher	Methods and compositions for treating schizophrenia
EP3761983A1 (de)	2018-03-05	2021-01-13	Alkermes Pharma Ireland Limited	Dosierstrategie für aripiprazol

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5206366A (en) *	1992-08-26	1993-04-27	Pfizer Inc.	Process for preparing aryl piperazinyl-heterocyclic compounds
US5312925A (en) *	1992-09-01	1994-05-17	Pfizer Inc.	Monohydrate of 5-(2-(4-(1,2-benzisothiazol-3-yl)-1-piperazinyl)-ethyl)-6-chloro-1,3-dihydro-2H-indol-2-one-hydrochloride
ATE254600T1 (de) *	1996-02-13	2003-12-15	Pfizer	Prodrogen von 5-(2-(4-(1,2-benzisothiazol-3-yl)-1-piperazinyl ethyl)-6-chloro-1,3-dihydro-2h-indol- 2-on
CA2340701C (en) *	1998-08-20	2009-05-26	Sumitomo Pharmaceuticals Co., Ltd.	Oxindole derivatives as growth hormone releasers

2003
- 2003-10-13 CA CA2500485A patent/CA2500485C/en not_active Expired - Fee Related
- 2003-10-13 MX MXPA05002734A patent/MXPA05002734A/es not_active Application Discontinuation
- 2003-10-13 DE DE60318602T patent/DE60318602T2/de not_active Expired - Fee Related
- 2003-10-13 PL PL376721A patent/PL376721A1/pl not_active Application Discontinuation
- 2003-10-13 AU AU2003269331A patent/AU2003269331B2/en not_active Ceased
- 2003-10-13 DK DK03751112T patent/DK1556378T3/da active
- 2003-10-13 NZ NZ566615A patent/NZ566615A/en not_active IP Right Cessation
- 2003-10-13 JP JP2004546256A patent/JP2006505578A/ja not_active Withdrawn
- 2003-10-13 BR BR0315516-1A patent/BR0315516A/pt not_active IP Right Cessation
- 2003-10-13 KR KR1020057006938A patent/KR100755625B1/ko not_active Expired - Fee Related
- 2003-10-13 AT AT03751112T patent/ATE383357T1/de not_active IP Right Cessation
- 2003-10-13 EP EP03751112A patent/EP1556378B1/de not_active Expired - Lifetime
- 2003-10-13 WO PCT/IB2003/004519 patent/WO2004037819A1/en not_active Ceased
- 2003-10-13 CN CNB2003801017404A patent/CN100340557C/zh not_active Expired - Fee Related
- 2003-10-13 PT PT03751112T patent/PT1556378E/pt unknown
- 2003-10-13 RU RU2005112254/04A patent/RU2005112254A/ru not_active Application Discontinuation
- 2003-10-13 ES ES03751112T patent/ES2297200T3/es not_active Expired - Lifetime
- 2003-10-21 US US10/689,773 patent/US7019009B2/en not_active Expired - Fee Related
- 2003-10-22 AR ARP030103846A patent/AR041695A1/es unknown
- 2003-10-23 TW TW092129426A patent/TW200418850A/zh unknown
2005
- 2005-03-14 ZA ZA200502109A patent/ZA200502109B/en unknown
- 2005-04-22 CO CO05038502A patent/CO5550441A2/es not_active Application Discontinuation
- 2005-05-23 NO NO20052475A patent/NO20052475L/no not_active Application Discontinuation
2008
- 2008-03-12 CY CY20081100276T patent/CY1107300T1/el unknown

Also Published As

Publication number	Publication date
TW200418850A (en)	2004-10-01
WO2004037819A1 (en)	2004-05-06
DK1556378T3 (da)	2008-03-17
EP1556378A1 (de)	2005-07-27
CN1705663A (zh)	2005-12-07
AR041695A1 (es)	2005-05-26
CN100340557C (zh)	2007-10-03
DE60318602T2 (de)	2009-01-15
NO20052475D0 (no)	2005-05-23
CA2500485A1 (en)	2004-05-06
DE60318602D1 (de)	2008-02-21
NO20052475L (no)	2005-07-25
AU2003269331A1 (en)	2004-05-13
RU2005112254A (ru)	2006-01-20
CY1107300T1 (el)	2012-11-21
ZA200502109B (en)	2006-05-31
HK1081185A1 (en)	2006-05-12
AU2003269331B2 (en)	2010-02-18
JP2006505578A (ja)	2006-02-16
US7019009B2 (en)	2006-03-28
CA2500485C (en)	2010-03-23
US20040138232A1 (en)	2004-07-15
NZ566615A (en)	2009-08-28
PL376721A1 (pl)	2006-01-09
KR20050065618A (ko)	2005-06-29
MXPA05002734A (es)	2005-05-23
PT1556378E (pt)	2008-02-21
CO5550441A2 (es)	2005-08-31
KR100755625B1 (ko)	2007-09-04
BR0315516A (pt)	2005-08-23
EP1556378B1 (de)	2008-01-09
ES2297200T3 (es)	2008-05-01

Similar Documents

Publication	Publication Date	Title
DK0904273T3 (da)	2003-07-07	Mesylat-trihydratsalt af 5-(2-(4-(1,2-benzisothiazol-3-yl)-1-piperazinyl)ethyl-6-chlor-1,3-dihydro-2(1H)-indol-2-on(=ziprasidon), dets fremstilling og dets anvendelse som dipamin D2 antagonist
FI933804L (fi)	1994-03-02	Monohydrat av 5-(2-(4-(1,2-bensisotiazol-3-yl)-1-piperazinyl)etyl-6-klor-1,3-dihydro-2H-indol-2-onkhydroklorid
NO985194L (no)	1998-11-06	Mesylat-dihydratsalter av 5-(2-(4-(1,2-benzisotiazol-3-yl)-1-piperazinyl)-etyl)-6-klor-1,3-dihydro-2(1H)-indol-2-on(ziprazidone), fremstilling derav og anvendelse derav som dopamin D2 antagonist
DE60211348D1 (de)	2006-06-14	2,4,5-trisubstituted thiazolyl derivative und deren antiinflammatorische wirkung
NO20050077L (no)	2005-02-03	Substituerte heterocykliske derivater som er anvendelige som antidiabetes- og antiovervektsmidler
PE20030942A1 (es)	2003-11-08	Procedimiento de sintesis de una composicion de ziprasidona
DK1218372T3 (da)	2003-10-20	Nye heterocykliske forbindelser, der er anvendelige som reversible inhibitorer af cysteinproteaser
DE50302202D1 (de)	2006-04-06	Neue 2,5-disubstituierte pyrimidinderivate
DE60235249D1 (de)	2010-03-18	Piperazinderivate mit ccr1-rezeptor-antagonistischer wirkung
NO20044093L (no)	2004-11-24	N-{5-[4-(4-metylpiperazinometyl)-benzoylamido]-2-metylfenyl}-4-(3-pyridyl)-2-pyrimidinamin belagte stenter
MA25658A1 (fr)	2002-12-31	Sels hydrochlores de 5(4-(2-(n-methyl-n-(2-pyridil) amino) ethoxy) benzyl) thyazolidine-2,4-dione.
PT1103545E (pt)	2004-03-31	2-(3,5-bis-trifluorometil-fenil)-n-metil-n-(6-morfolin-4-il-4-o-totil-piridin-3-il)-isobutiramida
ATE510556T1 (de)	2011-06-15	Verwendung von erythropoietin
FI956279L (fi)	1995-12-27	Menetelmiä ja välituotteita 5-/2-(4-(bentsoisotiatsol-3-yyli)piperatsin-1-yyli)etyyli/-6-kloori-1,3-dihydroindol-2-onin valmistamiseksi
AR028281A1 (es)	2003-04-30	Derivados de 2-(arilalquilamino) pirimidona y derivados de 2-(heteroaroarilalquilamino) pirimidona
ATE383357T1 (de)	2008-01-15	Acylderivate von 5-(2-(4-(1,2 benzisothiazol-3- yl)-1-piperazinyl)ethyl)-6-chloro-1,3-dihydro-2 - indol-2-on mit neuroleptischer wirkung
NO20040404L (no)	2004-01-29	2- (3,5-bis-trifluorometyl-fenyl) - N - [6-(1,1-diokso-1lam bda6-tiomorfolin-4-yl) - 4 - (2-metyl- eller 4-fluor-2-metylsubstituert) fenyl-pyridin-3-yl] -N-metyl-isobutyrami.
ATE381541T1 (de)	2008-01-15	Aminotetralinderivate, antagonisten von muscarinrezeptoren
ATE492535T1 (de)	2011-01-15	4-piperidinylalkylamin-derivate, antagonisten von muscarinrezeptoren
DE602004023417D1 (de)	2009-11-12	Oxazolderivate von tetracyclinen
MA28811B1 (fr)	2007-08-01	Nouvelles utilisations de derives d'imidazotriazinones substituees par 2-phenyle
ATE222456T1 (de)	2002-09-15	Stabilisierung von isothiazolonen
ATE484503T1 (de)	2010-10-15	2-pyrrolidin-2-yl-ä1,3,4ü -oxadiazol-derivate und ihre verwendung als antidepressiva
ATE525362T1 (de)	2011-10-15	2-(3-(4-(2-t-butyl-6-trifluormethylpyrimidin-4-
DK1015446T3 (da)	2003-07-14	4-(Piperidinyl)-1H-2-benzopyranderivater, der er nyttige som antipsykotiske midler

Legal Events

Date

Code

Title

Description

2008-08-15

UEP

Publication of translation of european patent specification

Ref document number: 1556378

Country of ref document: EP

2010-07-15

REN

Ceased due to non-payment of the annual fee